NeoStem, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Thursday’s Pre-Market Insights: GPRO, NBS, VRX, CTRP
Article By: TipRanks
Thursday, May 28, 2015 8:45 AM EDT
Thursday’s Pre-Market Insights: GPRO, NBS, VRX, CTRP.
In this article: GPRO, NBS, VRX, CTRP
Read
E NeoStem Advances New Cutting Edge Melanoma Treatment
Article By: Terry Chrisomalis
Friday, May 22, 2015 6:30 PM EDT
NeoStem (NBS) receives large research grant for cutting edge scientific Melanoma treatment.
In this article: NBS
Read
LabCorp (LH) Posts Strong Q1 Earnings Post-Covance Buyout
Article By: Zacks Investment Research
Monday, April 27, 2015 1:09 PM EDT
Laboratory Corporation of America Holdings (LH), or LabCorp, reported a solid first-quarter 2015 with adjusted earnings per share (EPS) of $1.73, up 14.6% from the year-ago quarter.
In this article: LH, ABC, BDX, NBS
Read
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak
Article By: The Life Sciences Report
Friday, November 14, 2014 6:49 AM EDT
Mdtech analyst that has allowed the WBB Securities cofounder to develop a reasoned perspective on how West Africa's Ebola epidemic might be humanely halted. Brozak also mentions small-cap names that could considerably enhance investors' portfolios.
In this article: GSK, JNJ, NBS, BCRX, OMER, TKMR, CEMP, SRPT, CMRX, TTPH, NAVB
Read
Biotechs With Upside Possibilities Target Ebola And Liver Disease: MLV & Co.'s Vernon Bernardino
Article By: The Life Sciences Report
Wednesday, September 10, 2014 3:43 PM EDT
In this interview with The Life Sciences Report, Vernon Bernardino of MLV & Co. brings some clarity and perspective to investors who could reap windfalls from small-cap names in which shareholder value has yet to be created and realized.
In this article: NBS, GALT, BCRX, SHPG, DVAX, ICPT, ABBV, CNAT, GLMD, IMNP
Read

PARTNER HEADLINES

Latest Tweets for $NBS

No tweets yet!